AMCX vs GDEV

AMCX's Piotroski F-Score of 4/9 indicates weak financial health, signaling distress in operational efficiency and capital structure. The absence of an Altman Z-Score raises red flags for potential bankruptcy risk, especially given a high Debt/Equity ratio of 1.83. While the stock trades at a deeply discounted valuation (P/E 4.34, Price/Book 0.31), its negative revenue growth (-0.80% YoY) and inconsistent earnings performance undermine long-term viability. The Graham Number of $29.31 suggests significant undervaluation, but the intrinsic value of $11.62 reflects low growth expectations and high risk. Overall, the combination of weak fundamentals, poor insider sentiment, and deteriorating trends makes the stock a high-risk proposition.

GDEV presents a classic 'value trap' profile, characterized by a stable Piotroski F-Score of 6/9 and an extremely low P/E of 3.71, yet offset by severe balance sheet distress. While the intrinsic value of $26.39 suggests significant upside from the current price of $13.99, the company suffers from negative equity (P/B -2.42) and poor liquidity (Current Ratio 0.67). Despite strong gross margins and a high ROA, declining year-over-year revenue and a 0/100 technical trend indicate strong bearish momentum that outweighs the valuation appeal.